These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 32020427)
1. Morin exerts anti-metastatic, anti-proliferative and anti-adhesive effect in ovarian cancer cells: an in vitro studies. Nowak E; Sypniewski D; Bednarek I Mol Biol Rep; 2020 Mar; 47(3):1965-1978. PubMed ID: 32020427 [TBL] [Abstract][Full Text] [Related]
2. Anticancer efficacy of cisplatin and trichostatin A or 5-aza-2'-deoxycytidine on ovarian cancer. Meng F; Sun G; Zhong M; Yu Y; Brewer MA Br J Cancer; 2013 Feb; 108(3):579-86. PubMed ID: 23370212 [TBL] [Abstract][Full Text] [Related]
3. PD98059 impairs the cisplatin-resistance of ovarian cancer cells by suppressing ERK pathway and epithelial mesenchymal transition process. Hou L; Hou X; Wang L; Li Z; Xin B; Chen J; Gao X; Mu H Cancer Biomark; 2017 Dec; 21(1):187-194. PubMed ID: 29103028 [TBL] [Abstract][Full Text] [Related]
4. Investigation of role of CpG methylation in some epithelial mesenchymal transition gene in a chemoresistant ovarian cancer cell line. Alghamian Y; Soukkarieh C; Abbady AQ; Murad H Sci Rep; 2022 May; 12(1):7494. PubMed ID: 35523936 [TBL] [Abstract][Full Text] [Related]
5. Morin, a flavonoid from Moraceae, suppresses growth and invasion of the highly metastatic breast cancer cell line MDA-MB‑231 partly through suppression of the Akt pathway. Jin H; Lee WS; Eun SY; Jung JH; Park HS; Kim G; Choi YH; Ryu CH; Jung JM; Hong SC; Shin SC; Kim HJ Int J Oncol; 2014 Oct; 45(4):1629-37. PubMed ID: 24993541 [TBL] [Abstract][Full Text] [Related]
6. Human chorionic gonadotropin β regulates epithelial-mesenchymal transition and metastasis in human ovarian cancer. Liu N; Peng SM; Zhan GX; Yu J; Wu WM; Gao H; Li XF; Guo XQ Oncol Rep; 2017 Sep; 38(3):1464-1472. PubMed ID: 28713970 [TBL] [Abstract][Full Text] [Related]
7. [Inhibition of Histone Deacetylases Reverses Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells through a Slug Mediated Mechanism]. Rahimian A; Barati G; Mehrandish R; Mellati AA Mol Biol (Mosk); 2018; 52(3):474-481. PubMed ID: 29989579 [TBL] [Abstract][Full Text] [Related]
8. Ampelopsin reduces the migration and invasion of ovarian cancer cells via inhibition of epithelial-to-mesenchymal transition. Liu T; Liu P; Ding F; Yu N; Li S; Wang S; Zhang X; Sun X; Chen Y; Wang F; Zhao Y; Li B Oncol Rep; 2015 Feb; 33(2):861-7. PubMed ID: 25502786 [TBL] [Abstract][Full Text] [Related]
9. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition. Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of TPA‑induced metastatic potential by morin hydrate in MCF‑7 human breast cancer cells via the Akt/GSK‑3β/c‑Fos signaling pathway. Lee KS; Nam GS; Baek J; Kim S; Nam KS Int J Oncol; 2020 Feb; 56(2):630-640. PubMed ID: 31939617 [TBL] [Abstract][Full Text] [Related]
11. 6,12-Diphenyl-3, 9-diazatetraasterane-1, 5, 7, 11-tetracarboxylate Inhibits Proliferation, Migration and Promotes Apoptosis in Ovarian Cancer Cells. Chen P; Wang H; Li M; Yang L; Mou F; Singh B; He JY; Zhang W Dis Markers; 2020; 2020():5068067. PubMed ID: 32963636 [TBL] [Abstract][Full Text] [Related]
12. DNA methyltransferase inhibitors influence on the DIRAS3 and STAT3 expression and in vitro migration of ovarian and breast cancer cells. Nowak EM; Poczęta M; Bieg D; Bednarek I Ginekol Pol; 2017; 88(10):543-551. PubMed ID: 29192415 [TBL] [Abstract][Full Text] [Related]
13. 5-AZA-dC induces epigenetic changes associated with modified glycosylation of secreted glycoproteins and increased EMT and migration in chemo-sensitive cancer cells. Greville G; Llop E; Howard J; Madden SF; Perry AS; Peracaula R; Rudd PM; McCann A; Saldova R Clin Epigenetics; 2021 Feb; 13(1):34. PubMed ID: 33579350 [TBL] [Abstract][Full Text] [Related]
14. Morin, a Flavonoid from Moraceae, Inhibits Cancer Cell Adhesion to Endothelial Cells and EMT by Downregulating VCAM1 and Ncadherin. Lee J; Jin H; Lee WS; Nagappan A; Choi YH; Kim GS; Jung J; Ryu CH; Shin SC; Hong SC; Kim HJ Asian Pac J Cancer Prev; 2016; 17(7):3071-5. PubMed ID: 27509931 [TBL] [Abstract][Full Text] [Related]
15. Short-term stimulation with histone deacetylase inhibitor trichostatin a induces epithelial-mesenchymal transition in nasopharyngeal carcinoma cells without increasing cell invasion ability. Shen Z; Liao X; Shao Z; Feng M; Yuan J; Wang S; Gan S; Ha Y; He Z; Jie W BMC Cancer; 2019 Mar; 19(1):262. PubMed ID: 30902084 [TBL] [Abstract][Full Text] [Related]
16. The effect of sodium butyrate and cisplatin on expression of EMT markers. Mrkvicova A; Chmelarova M; Peterova E; Havelek R; Baranova I; Kazimirova P; Rudolf E; Rezacova M PLoS One; 2019; 14(1):e0210889. PubMed ID: 30653577 [TBL] [Abstract][Full Text] [Related]
17. Mechanism of Hirudin-Mediated Inhibition of Proliferation in Ovarian Cancer Cells. Kou J; Gao L; Ni L; Shao T; Ding J Mol Biotechnol; 2024 May; 66(5):1062-1070. PubMed ID: 38184808 [TBL] [Abstract][Full Text] [Related]
18. Acquisition of paclitaxel resistance via PI3K‑dependent epithelial‑mesenchymal transition in A2780 human ovarian cancer cells. Du F; Wu X; Liu Y; Wang T; Qi X; Mao Y; Jiang L; Zhu Y; Chen Y; Zhu R; Han X; Jin J; Ma X; Hua D Oncol Rep; 2013 Sep; 30(3):1113-8. PubMed ID: 23807572 [TBL] [Abstract][Full Text] [Related]
19. SMAD3 inducing the transcription of STYK1 to promote the EMT process and improve the tolerance of ovarian carcinoma cells to paclitaxel. Shi Y; Zhang J; Liu M; Huang Y; Yin L J Cell Biochem; 2019 Jun; 120(6):10796-10811. PubMed ID: 30701575 [TBL] [Abstract][Full Text] [Related]
20. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer. Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]